Literature DB >> 52685

Bifunctional major histocompatibility-linked genetic regulation of cell-mediated lympholysis to trinitrophenyl-modified autologous lymphocytes.

A M Schmitt-Verhulst, G M Shearer.   

Abstract

Murine thymus-derived lymphocytes can be sensitized in vitro to trinitrophenyl (TNP)-modified autologous spleen cells (1, 2). Cytotoxic effector cells were generated which were specific for TNP-modified target cells expressing the same H-2K and H-2D serological regions as the modified stimulator cells (3, 7). Spleen cells from two C57BL/10 congenic strains of mice sharing common I-C, S, and D regions, but differing at K, I-A, and I-B regions, generated different levels of lytic responses to the shared modified H-2Dd products upon sensitization with auto logous TNP-modified cells. Lymphocytes from an F1 between responder and nonresponder strain generated a level of cytolysis toward the H-2Dd modified specificity which was of the same order of magnitude as that obtained with the high responder, irrespective of whether F 1 or either parental strain of modified stimulator cell was used. These results suggest that the modification of H-2Dd products resulted in formation of new antigenic determinants in both parental strains. However, the difference observed in responsiveness appeared to be due to a gene or genes mapping in the K, I-A, or I-B region which influenced the ability of the responding lymphocytes to react to these modified H-2Dd products. Responsiveness was expressed as a dominant trait in the F1.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 52685      PMCID: PMC2189948          DOI: 10.1084/jem.142.4.914

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Lysis mediated by T cells and restricted by H-2 antigen of target cells infected with vaccinia virus.

Authors:  U Koszinowski; H Ertl
Journal:  Nature       Date:  1975-06-12       Impact factor: 49.962

2.  HL-A, immune-response genes, and disease.

Authors:  H O McDevitt; W F Bodmer
Journal:  Lancet       Date:  1974-06-22       Impact factor: 79.321

3.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

Review 4.  The H-2 model for the major histocompatibility systems.

Authors:  J Klein; D C Shreffler
Journal:  Transplant Rev       Date:  1971

5.  Autoimmune murine thyroiditis. IV. Localization of genetic control of the immune response.

Authors:  V Tomazic; N R Rose; D C Shreffler
Journal:  J Immunol       Date:  1974-03       Impact factor: 5.422

6.  The genetic control of T cell-meditated immunity. I. Characterization of a mouse strain whose low responsiveness is inherited as a recessive trait.

Authors:  H Vachek; E Kölsch
Journal:  Immunology       Date:  1974-10       Impact factor: 7.397

7.  Cell-medicated cytotoxicity against ectromelia virus-infected target cells. III. Role of the H-2 gene complex.

Authors:  I D Gardner; N A Bowern; R V Blanden
Journal:  Eur J Immunol       Date:  1975-02       Impact factor: 5.532

8.  A mouse B-cell alloantigen determined by gene(s) linked to the major histocompatibility complex.

Authors:  D H Sachs; J L Cone
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

9.  H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus.

Authors:  P C Doherty; R M Zinkernagel
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

10.  Antigen-specific thymus cell factors in the genetic control of the immune response to poly-(tyrosyl, glutamyl)-poly-D, L-alanyl--poly-lysyl.

Authors:  J Taussig; E Mozes; R Isac
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

View more
  31 in total

Review 1.  Lymphocytes. 1. Function. Genetic restrictions in the immune response.

Authors:  A J McMichael
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

2.  Cytolytic thymus-derived lymphocytes specific for allogeneic stimulator cells crossreact with chemically modified syngeneic cells.

Authors: 
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

3.  Direct cytotoxicity against chicken erythrocytes in mice. I. Fundamental nature of T cell-mediated cytotoxicity.

Authors:  C Kubo; K Nomoto; M Sato; K Takeya
Journal:  Immunology       Date:  1977-12       Impact factor: 7.397

Review 4.  HLA restriction of human cytotoxic T cells.

Authors:  A J McMichael
Journal:  Springer Semin Immunopathol       Date:  1980-05

5.  Role of the H-2s haplotype in survival of mice after infection with Trypanosoma cruzi.

Authors:  R A Wrightsman; S M Krassner; J D Watson; J E Manning
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

6.  Virus specificity of cytotoxic T lymphocytes generated during acute lymphocytic choriomeningitis virus infection: role of the H-2 region in determining cross-reactivity for different lymphocytic choriomeningitis virus strains.

Authors:  R Ahmed; J A Byrne; M B Oldstone
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

7.  Recognition and lysis of altered-self cells by macrophages. I. Modification of target cells by 2,4,6-trinitrobenzene sulphonic acid.

Authors:  S Kunin; R Gallily
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

8.  Multiple cytolytic T-cell clones with distinct cross-reactivity patterns coexist in anti-self + hapten cell lines.

Authors:  A Guimezanes; J L Davignon; A M Schmitt-Verhulst
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

9.  Mouse immunoglobulin isotypes mediating cytotoxicity of target cells by eosinophils and neutrophils.

Authors:  A F López; M Strath; C J Sanderson
Journal:  Immunology       Date:  1983-03       Impact factor: 7.397

10.  Immunization with SV40-transformed cells yields mainly MHC-restricted monoclonal antibodies.

Authors:  B G Froscher; N R Klinman
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.